explore -WSS

explore

author：focus 2025-09-30 04:34:52 - browse：1

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout Newsletter: Zepbound, Valneva's vaccine, and more

hotspot

WSS

Eli Lilly expects to double planned employment in Boston center

Solve the antibiotic resistance crisis with preventive drugs

FDA reorg will put new emphasis on investigations, sources say

STAT Summit: GSK CEO on pharma giant's new direction

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

A letter from the executive editor: STAT UnitedHealth investigation

focus

explore

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A letter from the executive editor: STAT UnitedHealth investigation

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Will Ozempic

Hepatitis C has a cure — but many Americans still lack access to it

Cancer diagnosis changes perspective doctor, former hospital CEO

At least 13 dead in Texas as scorching temps continue

FDA warns J&J's Abiomed: We will regulate your software

Cancer drug shortages should be causing more outrage

Senate committee scrutinizes Medicare Advantage brokers

focus

First transplant of an entire human eye performed

Carbon Health diabetes program, a test of data

STAT Summit: Michael J. Fox on progress in Parkinson's research

What is STAT's opinion section for?

STAT Readout Newsletter: Today's biggest biotech updates

Ventyx halts psoriasis drug development after lackluster trial results

focus

hotspot

hotspot

entertainment